Timothy Gray

Insider profile

Currently holds positions in Medimmune LLC and Anterix Inc.

Performance

Overall performance
4.2
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 19% 8.2% 15.1%
Success rate 90% 68% 82%
Transactions
11 64% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Financial Officer Medimmune LLC Nov. 1, 2011 -
Chief Financial Officer Anterix Inc. June 1, 2014 -
Timothy Gray's trades of NextNav Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
485.72
Quantity 69,895 +18.6%
Value US$747,262
Transaction date
Proposed sale
Price
202.80
Quantity 64,235
Value US$722,869
Transaction date
Sale
Price
347.89
Quantity 80,309 -35.5%
Value US$4,544,982
Transaction date
Proposed sale
Price
18.11
Quantity 1,405
Value US$25,440
US Anterix Inc. (ATEX)
Transaction date
Purchase
Price
22.07
Quantity 50 +0.1%
Value US$1,104
US Anterix Inc. (ATEX)
Transaction date
Proposed sale
Price
32.26
Quantity 16,666
Value US$537,595
US Anterix Inc. (ATEX)
Transaction date
Planned sale
Price
32.26
Quantity 16,666 -15.6%
Value US$537,645
US Anterix Inc. (ATEX)
Transaction date
Planned sale
Price
32.26
Quantity 16,666 -15.6%
Value US$537,645
US Anterix Inc. (ATEX)
Transaction date
Planned sale
Price
31.91
Quantity 16,667 -15.6%
Value US$531,844
US Anterix Inc. (ATEX)
Transaction date
Planned sale
Price
31.91
Quantity 16,667 -15.6%
Value US$531,844
US Anterix Inc. (ATEX)
Transaction date
Proposed sale
Price
31.91
Quantity 16,667
Value US$531,836
US Anterix Inc. (ATEX)
Transaction date
Planned sale
Price
32.53
Quantity 2,794 -3.0%
Value US$90,889
US Anterix Inc. (ATEX)
Transaction date
Planned sale
Price
32.53
Quantity 2,794 -3.0%
Value US$90,889
US Anterix Inc. (ATEX)
Transaction date
Planned sale
Price
32.01
Quantity 13,873 -12.9%
Value US$444,075
US Anterix Inc. (ATEX)
Transaction date
Planned sale
Price
32.01
Quantity 13,873 -12.9%
Value US$444,075
US Anterix Inc. (ATEX)
Transaction date
Proposed sale
Price
32.10
Quantity 16,667
Value US$534,979
US Anterix Inc. (ATEX)
Transaction date
Purchase
Price
29.04
Quantity 100 +0.1%
Value US$2,904
US Anterix Inc. (ATEX)
Transaction date
Purchase
Price
36.67
Quantity 100 +0.1%
Value US$3,667
US Anterix Inc. (ATEX)
Transaction date
Purchase
Price
42.64
Quantity 100 +0.1%
Value US$4,264
US Anterix Inc. (ATEX)
Transaction date
Purchase
Price
54.94
Quantity 100 +0.1%
Value US$5,494
US Anterix Inc. (ATEX)
Transaction date
Purchase
Price
59.64
Quantity 100 +0.1%
Value US$5,964
US Anterix Inc. (ATEX)
Transaction date
Purchase
Price
44.57
Quantity 225 +0.4%
Value US$10,029
US Anterix Inc. (ATEX)
Transaction date
Sale
Price
42.85
Quantity 3,338 -5.4%
Value US$143,034
US Anterix Inc. (ATEX)
Transaction date
Sale
Price
58.18
Quantity 2,094 -3.6%
Value US$121,829
US Anterix Inc. (ATEX)
Transaction date
Sale
Price
54.89
Quantity 3,254 -5.3%
Value US$178,602
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-25 2026-09-23
PlS Planned sale
69,895 +18.6%
485.72
US$747,262 		69,895 +18.6% 485.72 US$747,262
2026-09-23 2026-09-23
PrS Proposed sale
64,235
202.80
US$722,869 		64,235 202.80 US$722,869
2026-03-23 2026-03-20
S Sale
80,309 -35.5%
347.89
US$4,544,982 		80,309 -35.5% 347.89 US$4,544,982
2026-03-20 2026-03-20
PrS Proposed sale
1,405
18.11
US$25,440 		1,405 18.11 US$25,440
2025-08-21 2025-08-19
US Anterix Inc. (ATEX)
B Purchase
50 +0.1%
22.07
US$1,104 		50 +0.1% 22.07 US$1,104
2024-05-03 2024-05-03
US Anterix Inc. (ATEX)
PrS Proposed sale
16,666
32.26
US$537,595 		16,666 32.26 US$537,595
2024-05-03 2024-05-03
US Anterix Inc. (ATEX)
PlS Planned sale
16,666 -15.6%
32.26
US$537,645 		16,666 -15.6% 32.26 US$537,645
2024-05-03 2024-05-03
US Anterix Inc. (ATEX)
PlS Planned sale
16,666 -15.6%
32.26
US$537,645 		16,666 -15.6% 32.26 US$537,645
2024-05-03 2024-05-02
US Anterix Inc. (ATEX)
PlS Planned sale
16,667 -15.6%
31.91
US$531,844 		16,667 -15.6% 31.91 US$531,844
2024-05-03 2024-05-02
US Anterix Inc. (ATEX)
PlS Planned sale
16,667 -15.6%
31.91
US$531,844 		16,667 -15.6% 31.91 US$531,844
2024-05-02 2024-05-02
US Anterix Inc. (ATEX)
PrS Proposed sale
16,667
31.91
US$531,836 		16,667 31.91 US$531,836
2024-05-03 2024-05-01
US Anterix Inc. (ATEX)
PlS Planned sale
2,794 -3.0%
32.53
US$90,889 		2,794 -3.0% 32.53 US$90,889
2024-05-03 2024-05-01
US Anterix Inc. (ATEX)
PlS Planned sale
2,794 -3.0%
32.53
US$90,889 		2,794 -3.0% 32.53 US$90,889
2024-05-03 2024-05-01
US Anterix Inc. (ATEX)
PlS Planned sale
13,873 -12.9%
32.01
US$444,075 		13,873 -12.9% 32.01 US$444,075
2024-05-03 2024-05-01
US Anterix Inc. (ATEX)
PlS Planned sale
13,873 -12.9%
32.01
US$444,075 		13,873 -12.9% 32.01 US$444,075
2024-05-01 2024-05-01
US Anterix Inc. (ATEX)
PrS Proposed sale
16,667
32.10
US$534,979 		16,667 32.10 US$534,979
2023-02-27 2023-02-24
US Anterix Inc. (ATEX)
B Purchase
100 +0.1%
29.04
US$2,904 		100 +0.1% 29.04 US$2,904
2022-09-19 2022-09-16
US Anterix Inc. (ATEX)
B Purchase
100 +0.1%
36.67
US$3,667 		100 +0.1% 36.67 US$3,667
2022-06-01 2022-05-27
US Anterix Inc. (ATEX)
B Purchase
100 +0.1%
42.64
US$4,264 		100 +0.1% 42.64 US$4,264
2021-12-21 2021-12-20
US Anterix Inc. (ATEX)
B Purchase
100 +0.1%
54.94
US$5,494 		100 +0.1% 54.94 US$5,494
2021-12-06 2021-12-02
US Anterix Inc. (ATEX)
B Purchase
100 +0.1%
59.64
US$5,964 		100 +0.1% 59.64 US$5,964
2021-02-22 2021-02-19
US Anterix Inc. (ATEX)
B Purchase
225 +0.4%
44.57
US$10,029 		225 +0.4% 44.57 US$10,029
2020-09-02 2020-09-02
US Anterix Inc. (ATEX)
S Sale
3,338 -5.4%
42.85
US$143,034 		3,338 -5.4% 42.85 US$143,034
2020-06-08 2020-06-05
US Anterix Inc. (ATEX)
S Sale
2,094 -3.6%
58.18
US$121,829 		2,094 -3.6% 58.18 US$121,829
2020-06-08 2020-06-04
US Anterix Inc. (ATEX)
S Sale
3,254 -5.3%
54.89
US$178,602 		3,254 -5.3% 54.89 US$178,602